The 12 closest competitors and alternatives to ROSE DIAGNOSTICS INC. — ranked by similarity to what ROSE DIAGNOSTICS INC. actually does, not by market-cap band.
Subscribe to see ROSE DIAGNOSTICS INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ROSE Diagnostics Inc. is a healthcare and biotechnology company headquartered in Carlsbad, California. The company bridges the gap between pathology labs and cancer biopsies, notably developing the verifi LUNG test.
ROSE DIAGNOSTICS INC. is a company headquartered in United States. Its most recent funding round raised $2.2M in July 2026. Xcout tracks 10 named people at ROSE DIAGNOSTICS INC., including Andrew Morris (President).
4 more named people on record for ROSE DIAGNOSTICS INC., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $2.2M | — | |
| SEC Form D filing | $2.3M | — | |
| SEC Form D filing | $1M | — | |
| Seed | $1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to ROSE DIAGNOSTICS INC. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Close match by what they do
Decipher Biosciences, Inc. was a health care company located in San Diego, California, before being acquired by Veracyte, Inc.
Close match by what they do
Emerge Diagnostics, Inc. is a technology company specializing in diagnosis and custom software services, located in Carlsbad, California.
Biotech
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Close match by what they do
Definitive Diagnostics, Inc. is a biotechnology research company located in St. Louis, Missouri. The firm focuses on multi-cancer early detection platforms with high sensitivity research.
Close match by what they do
Biocept, Inc. is a molecular diagnostics company incorporated in Delaware with its headquarters and CLIA-certified laboratory located in San Diego, California. The company develops and commercializes proprietary liquid biopsy assays for biomarker testing in oncology.
Close match by what they do
Mesa Biotech, Inc. is a molecular diagnostic company headquartered in San Diego, California. The firm specializes in developing innovative diagnostic testing products and technologies for healthcare applications.
Pharmaceuticals, Biotechnology & Life Sciences
Pacific Edge Ltd is a biotechnology research company headquartered in Dunedin, New Zealand, specializing in genomic diagnostics and the commercialization of the Cxbladder family of tests.
Medical - Diagnostics & Research
Castle Biosciences, Inc. functions as a commercial-stage diagnostics firm, with its primary objective being the provision of both diagnostic and prognostic testing services, specifically targeting various dermatological cancers. Their flagship product, DecisionDx-Melanoma, represents an advanced multi-gene expression profile (GEP) assay engineered to assess the probability of metastasis in patients afflicted with invasive cutaneous melanoma. In addition to their leading solution, the company has created several other specialized, proprietary tests. Among these is DecisionDx-UM, a GEP test tailored to forecast the risk of metastasis for individuals with uveal melanoma, a less common malignancy of the eye. Another key offering is DecisionDx-SCC, a distinctive 40-gene expression profile test that utilizes a patient's unique tumor biology to predict their specific risk of squamous cell carcinoma metastasis, particularly for those presenting with recognized risk factors. Moreover, they offer DecisionDx DiffDx-Melanoma and myPath Melanoma, both proprietary GEP tests employed to assist in the accurate diagnosis of ambiguous pigmented lesions. These specialized testing services are provided by Castle Biosciences to patients predominantly through their healthcare providers. The organization commenced operations in 2007 and maintains its corporate headquarters in Friendswood, Texas.
Medical - Diagnostics & Research
Biodesix, Inc. is a public diagnostic solutions company founded in 2006 and headquartered in Louisville, Colorado. The company specializes in diagnostic testing and development services focused on discovering blood-based tests for cancer management.
Life Sciences
Pathwork Diagnostics developed molecular diagnostic tests for cancer, notably the Tissue of Origin test, which analyzes tumor gene-expression patterns to help identify the likely primary site of metastatic cancers when the origin is unknown. Its products served pathologists and oncologists managing patients with cancers of unknown primary.
Biotechnology
Resolution Bioscience is a precision medicine company specializing in cancer diagnostics, DNA sequencing, and liquid biopsy, located in Bellevue, Washington.
AI and Analytics
DELFI Diagnostics is a medical and diagnostic laboratory company headquartered in Palo Alto, California, focused on developing advanced blood-based liquid biopsy tests for early cancer detection.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for ROSE DIAGNOSTICS INC.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →